Applied Therapeutics, Inc. ( APLT) - Key Metrics
Stock symbol APLT is outdated, potentially delisted? Maybe it is available on other exchange?
APLT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q3 | $0.01 | -$0.13 | -$0.13 | -$0.13 |
| 2025Q2 | ? | -$0.15 | -$0.14 | -$0.14 |
| 2025Q1 | ? | -$0.15 | -$0.20 | -$0.20 |
| 2024Q4 | $0 | $0.32 | -$0.14 | -$0.14 |
| 2024Q3 | $0 | -$0.48 | -$0.16 | -$0.16 |
APLT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q3 | ? | -1.16 |
| 2025Q2 | ? | -0.53 |
| 2025Q1 | ? | -0.81 |
| 2024Q4 | ? | 0.68 |
| 2024Q3 | ? | -4.47 |
APLT
Price: $0.10
52 week price:
Earnings Per Share: -0.10 USD
P/E Ratio: -1.03
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 546852
Market Capitalization: 14.9 million